Partial agonism of the D₂R is a similarity of the three drugs reviewed. Each drug varies in affinity for both the D₂R and a diverse group of 5-HTRs, generating a distinct profile of clinical indications and adverse effects for each.
No takes yet. Share an insight, caveat, or question.
Frankel et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: